| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 108.16 mm | 108.16 mm | 108.16 mm | 108.16 mm | 108.16 mm | 108.16 mm |
| Cash burn (monthly) | 3.09 mm | 3.62 mm | 25.43 mm | 21.77 mm | 17.53 mm | 8.71 mm |
| Cash used (since last report) | 11.13 mm | 13.04 mm | 91.47 mm | 78.33 mm | 63.07 mm | 31.34 mm |
| Cash remaining | 97.03 mm | 95.12 mm | 16.69 mm | 29.83 mm | 45.09 mm | 76.82 mm |
| Runway (months of cash) | 31.4 | 26.3 | 0.7 | 1.4 | 2.6 | 8.8 |
| 13F holders | Current |
|---|---|
| Total holders | 147 |
| Opened positions | 27 |
| Closed positions | 20 |
| Increased positions | 44 |
| Reduced positions | 39 |
| 13F shares | Current |
|---|---|
| Total value | 326.51 bn |
| Total shares | 187.06 mm |
| Total puts | 338.50 k |
| Total calls | 177.70 k |
| Total put/call ratio | 1.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Carl L. G. Hansen | 55.80 mm | $0.00 |
| Baker Bros. Advisors | 27.53 mm | $80.65 bn |
| Baillie Gifford & Co | 12.24 mm | $35.85 bn |
| Voya Investment Management | 10.62 mm | $31.13 bn |
| Thiel Peter | 10.18 mm | $0.00 |
| Capital World Investors | 7.93 mm | $23.25 bn |
| Prosight Management | 7.35 mm | $21.54 bn |
| DCVC Bio | 7.31 mm | $0.00 |
| Ubs Global Asset Management Americas | 4.50 mm | $13.19 bn |
| Orbimed Advisors | 4.18 mm | $12.25 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Jan 26 | Veronique Lecault | Share option Common Shares | Grant | Acquire A | No | No | 3.42 | 539,265 | 1.84 mm | 5,201,069 |
| 1 Jan 26 | Tryn Stimart | Share option Common Shares | Grant | Acquire A | No | No | 3.42 | 539,265 | 1.84 mm | 4,646,012 |
| 1 Jan 26 | Carl L. G. Hansen | Share option Common Shares | Grant | Acquire A | No | No | 3.42 | 2,106,505 | 7.20 mm | 13,096,837 |
| 1 Jan 26 | Andrew Booth | Share option Common Shares | Grant | Acquire A | No | No | 3.42 | 808,898 | 2.77 mm | 8,751,849 |
| 18 Dec 25 | Thermopylae | Common Shares | Gift | Dispose G | No | No | 0 | 225,000 | 0.00 | 55,918,640 |
